| Date Filed | Type | Description |
| 06/07/2023 |
4
| Agarwal Shefali (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| Agarwal Shefali (See Remarks) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Paid exercise price by delivering 373,154 shares
@ $1.39, valued at
$518.7k
Exercised 56,527 options to buy
@ $1.39, valued at
$78.6k
Exercised 43,473 options to buy
@ $1.39, valued at
$60.4k
Exercised 400,000 options to buy
@ $1.39, valued at
$556k
|
|
| 06/22/2022 |
4
| Agarwal Shefali (Director) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 19,000 options to buy
@ $2.22, valued at
$42.2k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| Agarwal Shefali (See Remarks) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Sold 1,058 shares
@ $1.5, valued at
$1.6k
|
|
| 02/04/2022 |
4
| Agarwal Shefali (See Remarks) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Sold 2,639 shares
@ $1.37, valued at
$3.6k
|
|
| 01/28/2022 |
4
| Agarwal Shefali (See Remarks) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Sold 2,922 shares
@ $2.02, valued at
$5.9k
|
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Agarwal Shefali (Director) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 937 options to buy
@ $9.86, valued at
$9.2k
|
|
| 11/19/2021 |
4
| Agarwal Shefali (Director) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 38,000 options to buy
@ $9.48, valued at
$360.2k
|
|
| 11/19/2021 |
3
| Agarwal Shefali (Director) has filed a Form 3 on Gritstone bio, Inc. |
| 06/04/2021 |
4
| Agarwal Shefali (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 2,681 shares
@ $0
Granted 4,334 options to buy
@ $68.94, valued at
$298.8k
|
|
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Sold 2,522 shares
@ $13.54, valued at
$34.1k
|
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/05/2020 |
4
| Agarwal Shefali (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 16,000 options to buy
@ $26.59, valued at
$425.4k
|
|
| 03/26/2020 |
4
| Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 1,575 shares
@ $0
Sold 1,243 shares
@ $15.28, valued at
$19k
|
|
| 02/05/2020 |
4
| Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 12,856 shares
@ $0
Granted 61,834 options to buy
@ $21.39, valued at
$1.3M
|
|
| 01/27/2020 |
4
| Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Sold 1,843 shares
@ $24.64, valued at
$45.4k
Sold 2,630 shares
@ $20.44, valued at
$53.8k
|
|
| 01/07/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/06/2019 |
4
| Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 22,577 shares
@ $0
Granted 34,978 options to buy
@ $16.61, valued at
$581k
|
|
| 07/17/2019 |
4
| Agarwal Shefali (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 24,000 options to buy
@ $22.14, valued at
$531.4k
|
|
| 07/17/2019 |
3
| Agarwal Shefali (Director) has filed a Form 3 on FATE THERAPEUTICS INC |
| 06/17/2019 |
4
| Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Sold 1,195 shares
@ $11.97, valued at
$14.3k
|
|
| 06/14/2019 |
4
| Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 4,000 shares
@ $0 |
|
| 01/28/2019 |
4
| Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 32,894 shares
@ $0
Granted 151,620 options to buy
@ $9.12, valued at
$1.4M
|
|
|